Home > Income Statement > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Revenue

    Back to Income Statement
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹4,859 Cr₹4,565 Cr₹3,890 Cr₹3,688 Cr₹3,070 Cr

What is the latest Revenue of STRIDES PHARMA SCIENCE ?

The latest Revenue ratio of STRIDES PHARMA SCIENCE is ₹4,859 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹4,859 Cr
Mar2025₹4,565 Cr
Mar2024₹3,890 Cr
Mar2023₹3,688 Cr
Mar2022₹3,070 Cr

How is Revenue of STRIDES PHARMA SCIENCE Trending?

Years Revenue % Change
Mar2026 ₹4,859 Cr
6.43
Mar2025 ₹4,565 Cr
17.36
Mar2024 ₹3,890 Cr
5.47
Mar2023 ₹3,688 Cr
20.13
Mar2022 ₹3,070 Cr -

Compare Revenue of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹9,607.2 Cr -0.9% -3.6% 15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹474,396.0 Cr 0.6% 6% 14.6% Stock Analytics
DIVIS LABORATORIES ₹196,990.0 Cr 1.2% 10.5% 7.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,354.0 Cr -0.4% 11% 40.8% Stock Analytics
CIPLA ₹116,705.0 Cr -1.6% -2.1% -4.8% Stock Analytics
DR REDDYS LABORATORIES ₹94,790.0 Cr -4.6% -14.8% -8.4% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-0.9%

-3.6%

15.6%

SENSEX

-0.9%

-0.4%

-6.1%


You may also like the below Video Courses